What is the address of KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS?

The registered office of KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS is located at Kloosterstraat 116, 1700 Dilbeek.

Is KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS still active?

Yes. According to the CBE (29 October 2026) KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS is active, legal situation “Normale toestand”, started on 5 May 1987.

Is KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS registered on Peppol?

Yes, KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS is registered on the Peppol network with ID 0208:0430441656.

What is the enterprise number of KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS?

The enterprise number of KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS is BE0430441656.

Who are the directors of KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS?

According to the 2025 annual accounts, the directors of KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS are: MARC SPOTBEEN, SARA SPOTBEEN.

Is KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 May 1987; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS make in 2025?

KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS posted a profit after taxes of € 89,515 in financial year 2025.

What is the revenue of KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS?

As a small company, KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 87,211.

KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS

Q: When was KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS founded?

KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS was founded on 5 May 1987.

Dossier KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS, printed on 29 October 2026 from databakkes.be/en/0430441656/kinesitherapie-marc-spotbeen-marie-paul-willems. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS from Dilbeek, company number BE0430441656, closed financial year 2025 with a result of € 89,515 after tax. For that financial year KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS recorded a gross margin of € 87,211 and equity of € 1 million. Compared with financial year 2024, the result moved from € 68,003 to € 89,515. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Growing

€ 1 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 89,515

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 99,297

▲ 269% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 21,053 paid out

24 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 249,528

▼ 11% vs 2024

€ 32,224 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 9,462

▲ 224% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 15,696

▲ 70% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 39,108 Gross margin 2022: € 39,108 First fiscal year in the series	€ 99,246 Gross margin 2023: € 99,246 ▲ 154% vs 2022 (€ 39,108) Favourable step	€ 97,368 Gross margin 2024: € 97,368 ▼ 2% vs 2023 (€ 99,246) Unfavourable step	€ 87,211 Gross margin 2025: € 87,211 ▼ 10% vs 2024 (€ 97,368) Unfavourable step	▼ 10%
Profit after taxes	€ 31,246 Profit after taxes 2022: € 31,246 First fiscal year in the series	€ 72,798 Profit after taxes 2023: € 72,798 ▲ 133% vs 2022 (€ 31,246) Favourable step	€ 68,003 Profit after taxes 2024: € 68,003 ▼ 7% vs 2023 (€ 72,798) Unfavourable step	€ 89,515 Profit after taxes 2025: € 89,515 ▲ 32% vs 2024 (€ 68,003) Favourable step	▲ 32%
Equity	€ 1,018,303 Equity 2022: € 1,018,303 First fiscal year in the series	€ 1,091,101 Equity 2023: € 1,091,101 ▲ 7% vs 2022 (€ 1,018,303) Favourable step	€ 965,210 Equity 2024: € 965,210 ▼ 12% vs 2023 (€ 1,091,101) Unfavourable step	€ 1,033,672 Equity 2025: € 1,033,672 ▲ 7% vs 2024 (€ 965,210) Favourable step	▲ 7%
Total debts	€ 471,078 Total debts 2022: € 471,078 First fiscal year in the series	€ 325,503 Total debts 2023: € 325,503 ▼ 31% vs 2022 (€ 471,078) Favourable step	€ 336,834 Total debts 2024: € 336,834 ▲ 3% vs 2023 (€ 325,503) Unfavourable step	€ 295,739 Total debts 2025: € 295,739 ▼ 12% vs 2024 (€ 336,834) Favourable step	▼ 12%
Cash	€ 72,600 Cash 2022: € 72,600 First fiscal year in the series	€ 13,232 Cash 2023: € 13,232 ▼ 82% vs 2022 (€ 72,600) Unfavourable step	€ 26,891 Cash 2024: € 26,891 ▲ 103% vs 2023 (€ 13,232) Favourable step	€ 99,297 Cash 2025: € 99,297 ▲ 269% vs 2024 (€ 26,891) Favourable step	▲ 269%
Land & buildings	€ 822,710 Land & buildings 2022: € 822,710 First fiscal year in the series	€ 802,796 Land & buildings 2023: € 802,796 ▼ 2% vs 2022 (€ 822,710) Unchanged	€ 782,882 Land & buildings 2024: € 782,882 ▼ 2% vs 2023 (€ 802,796) Unchanged	€ 762,968 Land & buildings 2025: € 762,968 ▼ 3% vs 2024 (€ 782,882) Unchanged	▼ 3%
Retained profit	€ 840,711 Retained profit 2022: € 840,711 First fiscal year in the series	€ 913,509 Retained profit 2023: € 913,509 ▲ 9% vs 2022 (€ 840,711) Favourable step	€ 787,618 Retained profit 2024: € 787,618 ▼ 14% vs 2023 (€ 913,509) Unfavourable step	€ 856,080 Retained profit 2025: € 856,080 ▲ 9% vs 2024 (€ 787,618) Favourable step	▲ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 193,895 Dividend 2024: € 193,895 Unchanged (€ 0) Unchanged	€ 21,053 Dividend 2025: € 21,053 ▼ 89% vs 2024 (€ 193,895) Unchanged	▼ 89%
Bank debt	€ 389,263 Bank debt 2022: € 389,263 First fiscal year in the series	€ 310,685 Bank debt 2023: € 310,685 ▼ 20% vs 2022 (€ 389,263) Favourable step	€ 280,800 Bank debt 2024: € 280,800 ▼ 10% vs 2023 (€ 310,685) Favourable step	€ 249,528 Bank debt 2025: € 249,528 ▼ 11% vs 2024 (€ 280,800) Favourable step	▼ 11%
Balance sheet total	€ 1,522,763 Balance sheet total 2022: € 1,522,763 First fiscal year in the series	€ 1,448,418 Balance sheet total 2023: € 1,448,418 ▼ 5% vs 2022 (€ 1,522,763) Unchanged	€ 1,332,288 Balance sheet total 2024: € 1,332,288 ▼ 8% vs 2023 (€ 1,448,418) Unchanged	€ 1,358,086 Balance sheet total 2025: € 1,358,086 ▲ 2% vs 2024 (€ 1,332,288) Unchanged	▲ 2%

Key figures of KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS?

What happened at KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 89,515 (▲ 32% vs 2024). filed late Source: NBB ↗
May 5, 1987 Start of the company according to the CBE. KBO
Mar 25, 1987 New establishment in Dilbeek. KBO

In short

From € 31,246 profit in 2022 to € 89,515 profit in 2025.

Paid € 95,024 in corporate taxes since 2022.

Best year ever: 2025, with € 89,515 profit.

Paid out € 214,947 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

MARC SPOTBEEN

SARA SPOTBEEN

KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS

Ad Rem 50%

Kloosterhof 50%

Behind KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS are MARC SPOTBEEN and SARA SPOTBEEN. It owns 50% of Ad Rem and 50% of Kloosterhof itself.

Directors

According to the 2025 annual accounts

MARC SPOTBEEN

bestuurder

Also active at: Memisa-België, Woon- en Zorgcentrum Het Witte Huis, AD REM, KLOOSTERHOF

SARA SPOTBEEN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kloosterstraat 116

1700 Dilbeek

2.033.255.206

H. Moeremanslaan 25

1700 Dilbeek

Active since 25 March 1987

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0430.441.656

VAT number

BE 0430.441.656

Registered office

Kloosterstraat 116, 1700 Dilbeek

Names & denominations

KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

5 May 1987

Peppol

Active · Active since 26 Aug 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Activiteiten van hoofdkantoren

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS

Financials

What happened to KINESITHERAPIE MARC SPOTBEEN - MARIE PAUL WILLEMS?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions